Form 4: Peter J. Arduini Reports Acquisition of Deferred Share Units in Bristol-Myers Squibb Co.

Director Peter J. Arduini reports acquisition of deferred share units in Bristol-Myers Squibb Co. on June 30, 2024.

Summary

• Peter J. Arduini, a director of Bristol-Myers Squibb Co., reported the acquisition of 825.659 deferred share units on June 30, 2024.
• These units will be converted into shares of common stock upon settlement, which occurs when Arduini ceases to be a director or at a previously specified future date.
• The price per unit is $41.53.
• Following the transaction, Arduini beneficially owns 54,249.647 shares, including deferred compensation and reinvested dividends.

Sentiment

Score: 6

Explanation: The sentiment is neutral as it reflects a standard transaction disclosure. The acquisition of deferred share units is generally a positive sign, but it's a routine event.

Positives

• The acquisition of deferred share units indicates a continued investment and alignment of interests between the director and the company.
• The reinvestment of dividends shows a long-term commitment to Bristol-Myers Squibb.

Future Outlook

The deferred share units will be converted into common stock upon settlement when the reporting person ceases to be a director or at a future date previously specified by the reporting person.

Industry Context

Form 4 filings are routine disclosures required by the SEC to provide transparency into the transactions of company insiders, such as directors and officers, ensuring fair market practices.

Stakeholder Impact

• The transaction provides transparency to shareholders regarding the director's investment in the company.
• It reinforces the alignment of interests between management and shareholders.

Key Dates